Translate your oncology target into a preclinical candidate
[FREE TALK] How to translate your oncology target into a preclinical candidate
on June 17, at 5pm CET on zoom
By showcasing some real-life examples, we will discuss how to identify combination partners to extend the clinical indication space, how to use chemical probes for target validation and how to identify biomarkers for patient selection and as pharmacodynamic read-outs.
In this 45-minute interactive event, Dr. Martin Lange and Dr.Carlo Stresemann from NUVISAN-ICB will address the following points:
• Finding the right drug combination partner
• Chemical probe-based target validation
• Biomarkers for patient selection and pharmacodynamic read-outs
• Live Q&A Session
• Chemical probe-based target validation
• Biomarkers for patient selection and pharmacodynamic read-outs
• Live Q&A Session
Join us, it's 100% FREE.
REGISTER HERE: https://zoom.us/webinar/register/8016221288029/WN_oum_oziuQQOPzrFPVbH_Cw